Stepan Q3 2026 earnings

SCL · 2026-10-28 07:00 BMO ET · 8-K on SEC

Adjusted EBITDA up 18% YoY and 12% QoQ; net income up 64% YoY despite $5.6M restructuring charge.

Headline numbers

MetricActualYoYQoQ8-K location
Revenue$692.2M+17.0%+1.2%Ex. 99.1, Financial Summary
EPS (GAAP)$0.78+66.0%+0.21Ex. 99.1, Table I
EPS (adjusted)$0.94+96.0%+0.23Ex. 99.1, Table I
Net income$17.8M+64.0%+0.2Ex. 99.1, Table I
Adj. EBITDA$66.3M+18.0%+12.0%Ex. 99.1, Highlights
Adj. EBITDA margin9.6%+1.2 pp+0.5 ppEx. 99.1, Table I

Revenue breakdown

SegmentActualYoYShare of revenueNote
Surfactants$486.6M+15.0%70.3%Adjusted EBITDA up 27% YoY
Polymers$178.7M+24.0%25.8%Adjusted EBITDA up 4% YoY
Specialty Products$26.9M+12.0%3.9%Adjusted EBITDA up 5% YoY

Margins and costs

  • Gross margin 12.7% (prior 12.0%, change +0.7 pp)
  • Operating expenses $56.0M (+13.7% YoY)
  • One-offs in the quarter Restructuring charge $5.6M pre-tax ($1.4M after-tax); Environmental remediation $2.4M after-tax; Deferred compensation $0.1M after-tax expense
  • Effective tax rate 10.2% (prior-year 34.2%)
  • Non-GAAP bridge Excludes deferred compensation, environmental remediation, and business restructuring; these are non-operational items.

KPIs

MetricActualPrior quarterPrior yearChange
Global sales volume+3% YoY+3% YoY+3% YoYOrganic volume +7% YoY
Cash from Operations$29.3M$8.4M$5.7M+317% QoQ
Free cash flow$8.2M$-15.0M$-7.3M+155% QoQ

Guidance

not stated in the 8-K

What drove it

  • Revenue story Net sales up 17% YoY (+3% volume) driven by higher selling prices and favorable FX; Surfactants (+15%) and Polymers (+24%) led growth.
  • EPS story EPS growth driven by higher adjusted net income (+98% YoY) and lower tax rate.
  • One-off check Restructuring charge of $5.6M pre-tax ($1.4M after-tax) related to Project Catalyst.

The good

  • Adjusted EBITDA up 18% YoY and 12% QoQ
  • Surfactant adjusted EBITDA up 27% YoY
  • Specialty Products volume up 20% YoY
  • Cash from Operations $29.3M

The bad

  • Polymers adjusted EBITDA up only 4% YoY due to regulatory-mandated maintenance costs
  • Specialty Products adjusted EBITDA up only 5% YoY due to less favorable product mix

The ugly

  • none

Open questions

  • Impact of $28.5M land sale proceeds on debt reduction
  • Full-year Adjusted EBITDA growth guidance
Full release

Earnings: SCL — filed 2026-10-28

Stepan Co (SCL) · Form 8-K, Item 2.02 · Filed · SEC filing

Stepan Reports Third Quarter 2026 Results

Northbrook, Illinois, October 28, 2026 -- Stepan Company (NYSE: SCL) today reported:

Third Quarter 2026 Highlights

• Reported net income was $17.8 million, up 64% versus the prior year. Adjusted net income

Financial statements

Income Statement

Three Months Ended September 30, — Financial Summary ($ in thousands, except per share data)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Three Months Ended September 30, – % ChangeNine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025Nine Months Ended September 30, – % Change
Net Sales692,154590,28417.0%1,980,7721,778,22811.0%
Operating Income25,95921,79419.0%13,54768,047-80.0%
Net Income (Loss)17,81310,83964.0%-68241,891-102.0%
Earnings per Diluted Share0.780.4766.0%-0.031.83-102.0%
Adjusted Net Income *21,68810,94898.0%59,05342,21140.0%
Adjusted Earnings per Diluted Share *0.940.4896.0%2.581.8440.0%

Income Statement

Three Months Ended September 30, — Segment Results (in thousands)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Three Months Ended September 30, – % ChangeNine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025Nine Months Ended September 30, – % Change
Operating Income (Loss)Surfactants27,44015,71875.0%80,35058,01538.0%
Operating Income (Loss)Polymers14,56914,1043.0%45,86039,28117.0%
Operating Income (Loss)Specialty Products10,1859,6346.0%19,90720,400-2.0%
Operating Income (Loss)Total Segment Operating Income52,19439,45632.0%146,117117,69624.0%
Operating Income (Loss)Corporate Expenses-26,235-17,66249.0%-132,570-49,649167.0%
Operating Income (Loss)Consolidated Operating Income (Loss)25,95921,79419.0%13,54768,047-80.0%

Income Statement

Three Months Ended September 30, — (Unaudited – in 000's, except per share data)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Net Sales692,154590,2841,980,7721,778,228
Cost of Sales604,573519,2611,728,3581,559,857
Gross Profit87,58171,023252,414218,371
Operating Expenses:Selling13,72611,29940,75838,064
Operating Expenses:Administrative26,60722,86472,12367,079
Operating Expenses:Research, Development and Technical Services15,67014,22547,85843,575
Operating Expenses:Deferred Compensation378412,0011,606
Operating Expenses:56,04049,229162,740150,324
Operating Expenses:Business Restructuring5,58276,127
Operating Expenses:Operating Income25,95921,79413,54768,047
Other Income (Expense):Interest, Net-6,344-6,815-17,037-16,426
Other Income (Expense):Other, Net2121,5361,3773,344
Other Income (Expense):)-6,132-5,279-15,660-13,082
Other Income (Expense):Income (Loss) Before Provision for Income Taxes19,82716,515-2,11354,965
Other Income (Expense):Provision for Income Taxes2,0145,676-1,43113,074
Other Income (Expense):Net Income (Loss)17,81310,839-68241,891
Net Income (Loss) Per Common ShareBasic0.780.47-0.031.83
Net Income (Loss) Per Common ShareDiluted0.780.47-0.031.83
Shares Used to Compute Net Income Per Common ShareBasic22,90622,87522,89722,869
Shares Used to Compute Net Income Per Common ShareDiluted22,97822,89322,89722,888

Income Statement

Three Months Ended September 30, (in thousands)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Deferred CompensationOperating Income (Expense)-37-841-2,001-1,606
Deferred CompensationOther, net – Mutual Fund Gain-321,0391,2362,338
Deferred CompensationTotal Pre-Tax-69198-765732
Deferred CompensationTotal After-Tax-52149-581549

Income Statement

Three Months Ended September 30, (in millions)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025ChangeChange Due to Foreign Currency TranslationNine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025ChangeChange Due to Foreign Currency Translation
Net Sales692.2590.3101.98.51,980.81,778.2202.651
Gross Profit87.67116.60.7252.4218.4346.1
Operating Income2621.84.20.413.568-54.53.8
Pretax Income (Loss)19.816.53.30.4-2.155-57.13.9

Income Statement

Three Months Ended September 30, 2026 (in millions)

Three Months Ended September 30, 2026 – SurfactantsThree Months Ended September 30, 2025Three Months Ended September 30, 2026 – PolymersThree Months Ended September 30, 2025Three Months Ended September 30, 2026 – Specialty ProductsThree Months Ended September 30, 2025Three Months Ended September 30, 2026 – Unallocated CorporateThree Months Ended September 30, 2025Three Months Ended September 30, 2026 – ConsolidatedThree Months Ended September 30, 2025
Net Income17.8
Provision for Income Taxes2
Interest Expense, Net6.3
EBIT26.2
Other, Net Income-0.2
Operating Income27.414.610.2-26.226
Depreciation and Amortization20.88.71.50.331.3
Other, Net Income0.20.2
EBITDA57.5
Deferred Compensation0.10.1
Environmental Remediation3.13.1
Business Restructuring5.65.6

Income Statement

Nine Months Ended September 30, 2026 (in millions)

Nine Months Ended September 30, 2026 – SurfactantsNine Months Ended September 30, 2025Nine Months Ended September 30, 2026 – PolymersNine Months Ended September 30, 2025Nine Months Ended September 30, 2026 – Specialty ProductsNine Months Ended September 30, 2025Nine Months Ended September 30, 2026 – Unallocated CorporateNine Months Ended September 30, 2025Nine Months Ended September 30, 2026 – ConsolidatedNine Months Ended September 30, 2025
Net Income-0.7
Provision for Income Taxes-1.4
Interest Expense, Net17
EBIT14.9
Other, Net Income-1.4
Operating Income80.345.919.9-132.613.5
Depreciation and Amortization63.9264.40.995.2
Other, Net Income1.41.4
EBITDA110.1
Deferred Compensation0.80.8
Environmental Remediation3.43.4
Business Restructuring76.176.1
Adjusted EBITDA144.271.924.3-50.1190.3
($ in millions)Unallocated CorporateConsolidated
Net Income41.9
Provision for Income Taxes13.1
Interest Expense, Net16.4
EBIT71.4
Other, Net Income-3.3
Operating Income5839.320.4-49.668.1
Depreciation and Amortization62.924.74.41.393.3
Other, Net Income3.33.3
EBITDA164.7
Deferred Compensation-0.7-0.7
Environmental Remediation1.11.1
Adjusted EBITDA120.96424.8-44.6165.1

Balance Sheet

September 30, 2026 — September 30, 2026 and December 31, 2025

September 30, 2026December 31, 2025
ASSETSCurrent Assets982,764858,959
ASSETSProperty, Plant & Equipment, Net1,132,8911,219,627
ASSETSOther Assets274,742279,116
ASSETSTotal Assets2,390,3972,357,702
LIABILITIES AND STOCKHOLDERS’ EQUITYCurrent Liabilities742,975666,494
LIABILITIES AND STOCKHOLDERS’ EQUITYDeferred Income Taxes11,00811,450
LIABILITIES AND STOCKHOLDERS’ EQUITYLong-term Debt341,687340,975
LIABILITIES AND STOCKHOLDERS’ EQUITYOther Non-current Liabilities75,94094,773
LIABILITIES AND STOCKHOLDERS’ EQUITYTotal Stepan Company Stockholders’ Equity1,218,7871,244,010
LIABILITIES AND STOCKHOLDERS’ EQUITYTotal Liabilities and Stockholders’ Equity2,390,3972,357,702

(1) was $21.7 million, up 98% versus the prior year.

• EBITDA

(2) was $57.5 million versus $56.1 million in the prior year. Adjusted EBITDA

(2) was $66.3 million, up 18%, year-over-year.

• Global sales volume was up 3% year-over-year. Organic sales volume was up 7% year-over-year.

• Cash from Operations was $29.3 million during the quarter. Free cash flow

(3) for the quarter was $8.2 million and was negatively impacted by higher working capital requirements.

• Pre-tax earnings include a $5.6 million restructuring charge, related to the Company's previously announced Project Catalyst, inclusive of approximately 100 salaried position reductions or 7% of global salaried headcount.

• In October, the Company closed on its previously announced agreement to sell a parcel of land near its Millsdale site for $28.5 million. The full cash proceeds will be used to pay down debt.

YTD 2026 Highlights

• Reported net income was a $0.7 million loss versus $41.9 million of income in the prior year. The current year loss is entirely due to a $76.1 million pre-tax restructuring charge. The cash impact associated with this restructuring charge was approximately $12.8 million year-to-date. Adjusted net income

(1) was $59.1 million, up 40% versus the prior year.

• EBITDA

(2) was $110.1 million and Adjusted EBITDA

(2) was $190.3 million. Adjusted EBITDA was up 15% year-over-year.

• Organic sales volume was up 4% year-over-year.

“Quarterly earnings were up significantly, driven by improved results in all three segments. Third quarter adjusted EBITDA of $66.3 million was up 18% year-over-year due to global volume growth, margin recovery and Project Catalyst savings. Surfactant adjusted EBITDA was up 27% in the quarter and Polymers grew single digits including one time maintenance costs. Specialty Products adjusted EBITDA was up 5% driven by double digit volume growth," said Luis E. Rojo, President and Chief Executive Officer. "Surfactant organic sales volume was up 8% and Polymer sales volume was up 3% in the quarter. The Surfactant volume growth was broad-based and across most end markets. Within Polymers, the North American Rigid, Spray Foam and Phthalic Anhydride businesses delivered double digit¹ volume growth. We are pleased with the growth we achieved in several of our key strategic end markets despite ongoing global economic uncertainties and supply chain disruptions. We executed the organizational redesign phase of Project Catalyst during the quarter in line with expectations."

Financial Summary

Percentage Change in Net Sales

Net sales in the third quarter of 2026 increased 17% year-over-year. This increase reflects higher selling prices, mainly attributable to the pass-through of higher raw material costs and pricing actions, a 3% increase in sales volume and the favorable impact of foreign currency translation. Organic sales volume was up 7% year-over-year.

Segment Results²

Consolidated adjusted EBITDA

(2) increased $10.1 million, or 18%, in the quarter. This increase was primarily due to higher Surfactant earnings driven by sales volume growth and margin recovery.

• Surfactant net sales were $486.6 million for the quarter, up 15% versus the prior year. Selling prices were up 10% primarily due to pass through of higher raw material costs and pricing actions. Global Sales volume was up 3% and organic sales volume increased 8%. Double digit growth in the Consumer Products, Construction & Industrial and Oilfield end markets and to our Tier 2/3 customer base was partially offset by lower Crop Productivity demand. Foreign currency translation positively impacted net sales by 2%. Surfactant adjusted EBITDA

(2) for the quarter increased $10.2 million, or 27%, versus the prior year. This increase was primarily due to sales volume growth and margin recovery.

• Polymer net sales were $178.7 million for the quarter, a 24% increase versus the prior year. Selling prices were up 22%, primarily due to the pass-through of higher raw material costs. Sales volume increased 3% in the quarter. North American sales volume was up double digits, inclusive of significant growth in Spray Foam, partially offset by lower volumes in Europe and Asia. Foreign currency translation negatively impacted net sales by 1% during the quarter. Polymer adjusted EBITDA

(2) increased $0.9 million, or 4%, versus the prior year primarily due to sales volume growth that more than offset regulatory-mandated maintenance turnaround costs, that occur every 5 years, at the Company's Germany site.

• Specialty Products net sales were $26.9 million for the quarter, a 12% increase versus the prior year. Specialty Products sales volume increased 20% while³ adjusted EBITDA

(2) increased $0.6 million, or 5%. The increase in adjusted EBITDA

(2) was primarily due to higher sales volume in the medium chain triglycerides product line that was partially offset by less favorable product mix.

Outlook... (truncated)nue to de-leverage the balance sheet in 2026."

Notes

(1)

Adjusted net income and adjusted earnings per share are non-GAAP measures which exclude deferred compensation income/expense, certain environmental remediation-related costs as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.

(2)

EBITDA and adjusted EBITDA are non-GAAP measures. See Table VI for calculations and GAAP reconciliations of EBITDA and adjusted EBITDA.

(3)

Free cash flow is a non-GAAP measure and reflects cash generated from operations minus capital expenditures. Cash generated from operations was $29.3 million during the third quarter of 2026 and capital expenditures were $21.1 million.

Conference Call

Stepan Company will host a conference call to discuss its third quarter results at 9:00 a.m. ET (8:00 a.m. CT) on October 28, 2026. The call can be accessed by phone and webcast. To access the call by phone, please click on this

Registration Link, complete the form and you will be provided with dial in details and a PIN. To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time. The webcast can be accessed through the

Investors/Conference Calls page at www.stepan.com. A webcast replay of the conference call will be available at the same location shortly after the call.

Supporting Slides

Slides supporting this press release will be made available at www.stepan.com through the

Investors/Presentations page at approximately the same time as this press release is issued.

Corporate Profile

Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection compounds and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.⁴

Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.

The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com

More information about Stepan’s sustainability program can be found on the Sustainability page at www.stepan.com

Contact: Ruben Velasquez 847-446-7500

Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company’s plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “guidance,” “predict,” “potential,” “continue,” “likely,” “will,” “would,” “should,” “illustrative” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to our ability to realize cost savings or operating efficiencies associated with strategic initiatives, including Project Catalyst; accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws and other legal restrictions, including those relating to the international scope of our business; domestic and global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including changes in global trade policies, tariffs and retaliatory measures and countermeasures; currency exchange rate fluctuations; changes in tax policy and potential adverse tax consequences due to the international scope of our business; downgrades in our credit ratings or our ability to access the credit or capital markets if and when necessary; global political, military, security or other instability and increased security regulations; costs, delays and miscalculations in capacity needs related to expansion or other capital projects; interruption or breaches of information technology systems; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; our ability to retain executive management and key personnel; and issues relating to compliance with our debt covenants. In addition to the risks described in the Company's periodic reports, the restructuring actions described herein may involve risks related to the execution of facility closures and asset decommissioning, potential operational disruptions, impacts on employees and local communities, environmental compliance, and the realization of anticipated cost savings and efficiencies.⁵

These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable laws.

* * * * *

Tables follow⁶

Table I

STEPAN COMPANY

For the Three and Nine Months Ended September 30, 2026 and 2025

(Unaudited – in 000's, except per share data)⁷

Table II

Reconciliation of Non-GAAP Net Income (Loss) and Earnings per Diluted Share*

* All amounts in this table are presented after-tax

The Company believes that certain non-GAAP measures, in conjunction with comparable GAAP measures, are useful for evaluating the Company’s operating performance and financial condition. The Company uses this non-GAAP information as an indicator of business performance and evaluates management’s effectiveness with specific reference to these indicators. Management believes that these non-GAAP financial measures provide useful supplemental information because they exclude non-operational items that affect comparability between years. These measures should be considered in addition to, not as substitutes for or superior to, measures of financial performance prepared in accordance with GAAP and may differ from similarly titled measures presented by other companies. The Company's Annual Report on Form 10-K for the year ended December 31, 2025 contains additional information regarding the use of non-GAAP financial measures.

Summary of Third Quarter 2026 Adjusted Net Income Items

Adjusted net income excludes non-operational deferred compensation income/expense, certain environmental remediation costs and other significant and infrequent or non-recurring items.

• Deferred Compensation:

The third quarter of 2026 reported net income includes $0.1 million of after-tax expense versus $0.1 million of after-tax income in the prior year.

• Environmental Remediation:

The third quarter of 2026 reported net income includes $2.4 million of after-tax expense versus $0.3 million of after-tax expense in the prior year. The higher current year expense primarily reflects a reserve adjustment related to the Company's Maywood, NJ site.

• Business Restructuring:

The third quarter of 2026 reported net income includes $1.4 million of after-tax expense related to restructuring charges. There were no restructuring charges recognized in the prior year quarter.⁸

Table III

Reconciliation of Pre-Tax to After-Tax Adjustments

Management uses the non-GAAP adjusted net income metric to evaluate the Company's operating performance. Management excludes the items listed in the table below because they are non-operational items. The cumulative tax effect is typically calculated using the statutory tax rates for the jurisdictions in which the transactions occurred.⁹

Table IV

Deferred Compensation Plans

The full effect of the deferred compensation plans on quarterly pre-tax income was $0.1 million of expense versus $0.2 million of income in the prior year. The quarter-end market prices of Company stock and the impact of deferred compensation on specific income statement line items is summarized below:

Effects of Foreign Currency Translation

The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. These results are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. The table below presents the impact that foreign currency translation had on select income statement line items.

Corporate Expenses

Adjusted Corporate expenses increased $1.0 million, or 6%, for the quarter. This increase was primarily due to higher incentive-based compensation expenses.¹⁰

Table V

Stepan Company

Consolidated Balance Sheets

September 30, 2026 and December 31, 2025

Selected Balance Sheet Information

The Company’s total debt decreased by $13.3 million and cash decreased by $15.6 million versus June 30, 2026. The Company’s net debt level increased $2.3 million versus June 30, 2026 and its net debt ratio was 31% which was constant with the prior quarter (

Net Debt and

Net Debt Ratio are non-GAAP measures, reconciliations of which are shown in the table below).

Management uses the non-GAAP net debt metric to show a more complete picture of the Company's overall liquidity, financial flexibility and leverage level.

The major working capital components were:¹¹

Table VI

Reconciliations of Non-GAAP EBITDA and Adjusted EBITDA

Management uses the non-GAAP EBITDA and adjusted EBITDA metrics to evaluate the Company's operating performance. Management excludes the items listed in the table below because they are non-operational items.¹²¹³

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Stepan earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.